DocuSign (NASDAQ:DOCU – Get Rating) had its price objective reduced by equities research analysts at Piper Sandler from $100.00 to $75.00 in a research note issued to investors on Friday, The Fly reports. Piper Sandler’s price objective would suggest a potential downside of 14.15% from the stock’s previous close. Several other analysts have also recently […]